At our recent conference Genomic Analysis in Tort Cases, panelists addressed the use of genomics in medical cases (birth defects, malpractice, drugs). The panel was composed of an attorney, a medical doctor, and a genetic scientist. Dr. van Zyl, the genetic scientist, provided insightful information as to why individual genetic variability matters, including for Absorption, Distribution, Metabolism, and Elimination (ADME) genes which contribute significantly to the inter-individual variability in efficacy and toxicity of numerous drugs from practically all therapeutic categories. Dr. Tom Morgan, a medical doctor with genetics expertise, addressed the role of genomics in impaired childhood development and birth injury cases by providing good background information and specific case examples. Finally, Mr. Gendron provided the legal perspective to this panel through is discussion and insights on Federal Rule of Civil Procedure 35(a) and its intersection with genomics in the courtroom.

The slides from this panel can be downloaded by completing the form below. The slides contain material from all Use of Genomics in Medical Cases (Birth Defects, Malpractice, Drugs) panelists, which included Andrew Gendron, Esq. (Lewis Brisbois Bisgaard & Smith LLP), Thomas M. Morgan, M.D. (Vanderbilt Children’s Hospital), and Leonel M. van Zyl, Ph.D., (ToxicoGenomica).